Option chain shows key data for HUTN's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for HUTN.

HUTN (OTC:HUTN) Stock, Option Chain

HUTN Inc is a non-operating holding company engages in the provision of B2C internet services. It sells and distribute their products and services to consumers through the internet and generates revenue from the subscription services.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ADAP

ADGO

AEYE

AIHS

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ANDE

APEI

Adtalem Global Education Inc. Common Stock

ATGE

ATVK

AXAS

AXTI

BARRF

BBIO

BCDS

BIOL

BLFR

BRSWQ

BRTX

BTCS

BTLLF

CCAN

CCRC

CDEV

CELLCUBE ENERGY STORAGE by Cellcube Energy Storage Sys Inc.

CECBF

CELC

CGNSF

CHCX

CLVS

CMCT

CNONF

CNSL

COBALT BLOCKCHAIN INC by Cobalt Blockchain Inc.

COBCF

CRTPF

CRUUF

CRYCY

DKAM

DLOC

ELOX

EMESQ

EWLL

EZCL

FSDDF

FUAPF

GALXF

GEMP

GNFT

GNFTF

GRTD

HAON

HTBX

HUTN

INMB

IRNC

JAGX

KALV

KOIOS BEVERAGE CORP by Koios Beverage Corp.

KBEVF

LIVX

LRSNF

LRTTF

LTMCF

MAKSY

MAYS

MINE

MMMM

MORF

MRNJ

MARICANN GROUP INC ORD by Maricann Group Inc

MRRCF

MRSN

MYMMF

MYOV

NANX

NEOM

NMTC

NSPXD

NUGS

OMAG

PBBSF

PEYUF

PGPEF

PHMB

PNAT

PPSI

PRPM

PTAIF

RTIX

SCON

SLCA

SPLIF

Stocks That Hit 52-Week Lows Of Monday

HUTN Inc

Needham analyst Mike Cikos maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Buy and raises the price target from $200 to $215.

Price Target

Analyst Ratings

SNOW

Needham Maintains Buy on Snowflake, Raises Price Target to $215

B of A Securities analyst Elizabeth Suzuki maintains Lowe's Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) with a Buy and lowers the price target from $305 to $290.

B of A Securities Maintains Buy on Lowe's Companies, Lowers Price Target to $290

Novavax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.32) by 6.82 percent. This is a 77.26 percent increase over losses of $(5.41) per share from the same period last year. The company reported quarterly sales of $682.16 million which missed the analyst consensus estimate of $684.94 million by 0.41 percent. This is a 30.65 percent decrease over sales of $983.71 million the same period last year.

Earnings

NVAX

Novavax FY 2024 GAAP EPS $(1.23) Beats $(1.32) Estimate, Sales $682.16M Miss $684.94M Estimate

B of A Securities analyst Brad Sills maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Buy and lowers the price target from $440 to $400.

B of A Securities Maintains Buy on Salesforce, Lowers Price Target to $400

Needham analyst Mike Cikos maintains Nutanix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) with a Buy and raises the price target from $90 to $92.

NTNX

Needham Maintains Buy on Nutanix, Raises Price Target to $92

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) has stabilized in Thursday morning trading, following another day of <a href="https://www.benzinga.com/money/best-spot-bitcoin-etfs">heavy spot ETF outflow</a>s on Wednesday.
What Happened: The apex crypto is trading around $86,500 at the time of writing, down 1.8% over the past 24 hours, but up from its slump below the $84,000 mark on Wednesday.
Spot ETFs saw another day of strong outflows, with BlackRock&#8216;s iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) recording its largest single-day outflow, coinciding with President Trump&#8217;s threats of <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43987636/bitcoin-tumbles-below-85000-amid-president-trumps-eu-tariff-threats">new tariffs on the European Union</a>.
According to <a href="https://sosovalue.xyz/zh/assets/etf">data</a> from SoSoValue, IBIT saw record net outflows of $418.1 million on Wednesday, surpassing its previous record of $332.6 million set on Jan. 2. Total net outflows on Wednesday tallied $754.54 million.
This outflow is part of a larger trend, with U.S. spot Bitcoin ETFs experiencing a seven-day negative streak totaling nearly $3 billion in outflows.
Despite the recent outflows, IBIT remains the largest U.S. spot Bitcoin ETF with over $40.2 billion in cumulative net inflows and $51.6 billion in assets under management. 
The fund continues to dominate trading volume, accounting for 72% of Wednesday&#8217;s $5.7 billion in trading activity across all spot Bitcoin ETFs.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43997635/bitcoin-spin-off-litecoin-ethereum-killer-avalanche-weather-crypto-meltdown-heres-why-ltc-avax-are-spiking">Bitcoin Spin-Off Litecoin, &#8216;Ethereum Killer&#8217; Avalanche Weather Crypto Meltdown, Here&#8217;s Why LTC, AVAX Are Spiking</a>
Why It Matters: The crypto market&#8217;s downturn has been exacerbated by President Trump&#8217;s remarks threatening 25% tariffs on the European Union. As reported by the Financial Times, Trump stated that a decision has been made and will be announced &#8220;very soon,&#8221; leading to increased market uncertainty and risk-off sentiment.
In response to the market volatility, 21Shares Crypto Research Strategist Matt Mena highlighted potential positive catalysts that could reverse the trend.
Mena <a href="https://www.theblock.co/post/343709/21shares-sees-nvidia-earnings-and-fridays-pce-data-as-potential-catalysts-for-bitcoin-boost?utm_source=rss&amp;utm_medium=rss">told</a> The Block, &#8220;A positive regulatory tailwind, combined with strong Nvidia earnings — which signal continued AI-driven demand and boost overall risk sentiment — along with positive PCE inflation numbers this Friday, could create the perfect macro environment for bitcoin to not only reclaim its previous highs but potentially push beyond $150,000 as institutional and retail confidence surges.&#8221;
Nvidia reported solid figures in its <a href="https://www.benzinga.com/markets/equities/25/02/43999126/nvidias-q4-revenue-surges-to-393b-nearly-8x-higher-than-five-years-ago-analysts-debate-stocks-next-move">Wednesday earnings report</a>, with fourth-quarter revenue of $39.3 billion marking an eight-fold increase compared to 2020.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/44000111/jim-cramer-says-misunderstood-robinhood-stock-not-merely-a-crypto-play-its-an-investment-in-the-way-the-next-generations-will-invest">Jim Cramer Says &#8216;Misunderstood&#8217; Robinhood Stock Not Merely A Crypto Play: &#8216;It&#8217;s An Investment In The Way The Next Generations Will Invest&#8217;</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

IBIT

Bitcoin Steadies Around $86,500 As Spot ETF See Another $750 Million Outflows On Wednesday

B of A Securities analyst Vivek Arya maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $190 to $200.

NVDA

B of A Securities Maintains Buy on NVIDIA, Raises Price Target to $200

Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) with a Buy and lowers the price target from $60 to $59.

RVMD

Needham Maintains Buy on Revolution Medicines, Lowers Price Target to $59

Rosenblatt analyst Kevin Cassidy maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Neutral and maintains $49 price target.

Rosenblatt Maintains Neutral on ON Semiconductor, Maintains $49 Price Target

Needham analyst Quinn Bolton reiterates IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) with a Buy and maintains $54 price target.

Reiteration

IONQ

Needham Reiterates Buy on IonQ, Maintains $54 Price Target

CNBC&#8217;s Jim Cramer commented on the tight trading of Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), attributing it to the market&#8217;s struggle to value the company&#8217;s impressive earnings. Despite stellar fourth quarter results, Nvidia stock rose just 1% during the pre-market trading session on Thursday.
What Happened: On February 27, Cramer posted on X, &#8220;The tight trading in Nvidia is more of a sign that no one knows how to value amazing earnings than it is that there is something wrong. In another post, Cramer stated, &#8220;People will wonder if Nvidia has now become a &#8216;perfect&#8217; security.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The tight trading in Nvidia is more of a sign that no one knows how to value amazing earnings than it is that there is something wrong.
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1895049690330136868?ref_src=twsrc%5Etfw">February 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
However, Cramer&#8217;s comment suggests that despite these impressive earnings, the market is struggling to accurately value Nvidia&#8217;s stock, leading to its tight trading. This uncertainty may cause some to question whether Nvidia has become a &#8220;perfect&#8221; security, as Cramer puts it.
SEE ALSO: <a href="https://www.benzinga.com/trading-ideas/movers/25/02/43997635/bitcoin-spin-off-litecoin-ethereum-killer-avalanche-weather-crypto-meltdown-heres-why-ltc-avax-are-spiking">Bitcoin Spin-Off Litecoin, &#8216;Ethereum Killer&#8217; Avalanche Weather Crypto Meltdown, Here&#8217;s Why LTC, AVAX Are Spiking</a>
Why It Matters: Cramer&#8217;s post comes after <a href="https://www.benzinga.com/markets/equities/25/02/43999126/nvidias-q4-revenue-surges-to-393b-nearly-8x-higher-than-five-years-ago-analysts-debate-stocks-next-move">Nvidia&#8217;s fourth quarter revenue</a> surged to $39.3 billion, nearly eight times higher than it was five years ago. Meanwhile, net income for the quarter surged to $22.09 billion, marking an 80% increase from $12.29 billion in the same period last year. 
Downplaying concerns over DeepSeek, Nvidia emphasized that highly advanced AI models would still demand significant processing power over time. CEO, Jensen Huang, stated that next-generation artificial intelligence models require &#8220;100 times more compute&#8221; than earlier versions. 
However, the market&#8217;s tepid reaction as highlighted by Jim Cramer could be due to an overall decline in consumer confidence in the U.S. economy. Moreover, the increasing AI dominance from Chinese tech giants continues to be a cause of concern for investors. 
According to Jacob Falkencrone, Global Head of Investment Strategy at Saxo Bank, &#8220;Wall Street isn't easy to impress, and after Nvidia's meteoric rise, expectations were sky-high. Investors were looking for a "beat and raise" moment—the kind of jaw-dropping numbers Nvidia has delivered in previous quarters. Instead, revenue guidance for Q1 came in at $43 billion, slightly above estimates but not the massive beat that would have justified another rally.&#8221;
Nevertheless, Falkencrone added, &#8220;This isn't to say Nvidia is in trouble—far from it. Demand for its AI chips remains extraordinary.&#8221;
Nvidia stock soared over 66% during the past 12 months, according to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/markets/25/02/44000386/trump-shuts-down-chevrons-venezuela-oil-permit-tightening-pressure-on-maduro-regime-crude-oil-prices-rise-on-supply-concerns">Trump Shuts Down Chevron&#8217;s Venezuela Oil Permit, Tightening Pressure On Maduro Regime: Crude Oil Prices Rise On Supply Concerns</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Tech

Nvidia Stock Climbs Only 1% In Thursday Pre-Market Despite Blockbuster Earnings: Jim Cramer Thinks It Is A 'Sign' Of This

Fiscal 2026 booking pace is also running significantly ahead compared to the same period a year ago. Banquet revenue is running similarly ahead of the same time last year, with catering revenue running slightly behind for 2025 but ahead for 2026.

Guidance

Marcus Group Says FY25 Booking Pace Is Running Ahead Of Pace YoY And Significantly Ahead Of Pace When Excluding Impact Of RNC

Financial Guidance for 2025&nbsp;
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Item</td>
<td colspan="4" rowspan="1">
2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA
(in millions)
</td>
</tr>
<tr>
<td colspan="2" rowspan="1">
&nbsp;
Net Revenue
</td>
<td colspan="1" rowspan="1">$153.0</td>
<td colspan="1" rowspan="1">
&nbsp;
to
</td>
<td colspan="1" rowspan="1">$163.0</td>
</tr>
<tr>
<td colspan="2" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">$0.0</td>
<td colspan="1" rowspan="1">to</td>
<td colspan="1" rowspan="1">$8.0</td>
</tr>
</tbody>
</table>
</figure>

Biotech

Health Care

HRTX

Heron Therapeutics Expects 2025 Sales Of $153M-$163M Versus Consensus Of $160.633M

GBTG

American Express Global Business Travel Sees FY25 Revenue Growth 5-7%

Earnings Beats

Global Business Travel Q4 Sales $591.000M Beat $589.170M Estimate

Cannabis

Canopy Growth Has Officially Launched Its Tweed Brand In The German Medical Cannabis Market, Including The Availability Of Four New Tweed Strains Grown In The Eu Through An Agreement With Gro-vida, A Portuguese Medical Cannabis Cultivator

Marcus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCS#NYSE">MCS</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.11 by 72.73 percent. This is a 160 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $188.31 million which beat the analyst consensus estimate of $183.00 million by 2.90 percent. This is a 16.58 percent increase over sales of $161.53 million the same period last year.

Earnings Misses

Marcus Q4 2024 GAAP EPS $0.03 Misses $0.11 Estimate, Sales $188.31M Beat $183.00M Estimate

Rosenblatt analyst Steven Frankel maintains Xperi (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPER#NYSE">XPER</a>) with a Buy and maintains $15 price target.

XPER

Rosenblatt Maintains Buy on Xperi, Maintains $15 Price Target

Heron Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTX#NASDAQ">HRTX</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.03) by 166.67 percent. This is a 128.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $40.78 million which beat the analyst consensus estimate of $37.37 million by 9.14 percent. This is a 19.13 percent increase over sales of $34.23 million the same period last year.

Heron Therapeutics Q4 2024 GAAP EPS $0.02 Beats $(0.03) Estimate, Sales $40.78M Beat $37.37M Estimate

TGNA

TEGNA Sees Q1 Revenue Decline Of (-4%) - (-7%)

Comments

HUTN

HUTN (HUTN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga